Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1344619

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment of how British nationals studying abroad may add their inoculation records to the NHS App for when they return to the UK after having been vaccinated against covid-19 in the foreign country where they reside.
tabling member constituency	Wycombe
tabling member printed	Mr Steve Baker
uin	29037
answer	answer is ministerial correction date of answer 15/07/2021 answer text <p>The NHS App can only display vaccinations delivered in England. Once a British national returns from abroad, they will need to contact their general practitioner who will have guidance about what can be used to verify that a person has received a vaccine dose and ensure this is represented on their vaccination history.</p><p>There are a large variety of COVID-19 vaccines being administered worldwide. Work is ongoing, including with international partners, to determine which non-United Kingdom vaccines can be recognised.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/07/2021 15:33:54 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4064 label Biography information for Mr Steve Baker

1344629

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether people over 40 years old are required to wait up to 12 weeks for their second covid-19 vaccine.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	29079
answer	answer is ministerial correction date of answer 14/07/2021 answer text <p>Since June 2021, second doses for all over 40 year olds have been administered on an eight-week interval after their first dose. All over 40 year olds who received a first dose by mid-May will be offered a second dose by 19 July.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/07/2021 16:05:45 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4471 label Biography information for Rachael Maskell

1344630

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people have contracted covid-19 after (a) one vaccine, (b) at least three weeks after the first vaccine, (c) two vaccines and (d) at least two weeks after the second vaccine.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	29080
answer	answer is ministerial correction date of answer 14/07/2021 answer text <p>Data on how many people have contracted COVID-19 after one vaccine, at least three weeks after the first vaccine, two vaccines and at least two weeks after the second vaccine is not available in the format requested.</p><p>Public Health England monitors the number of people who have tested positive for COVID-19 after they have received one or two doses of the vaccine and these data are used to calculate vaccine effectiveness estimates which are published at regular intervals.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/07/2021 11:51:24 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 13481 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4471 label Biography information for Rachael Maskell

1344635

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the covid-19 transmission rates for people who have had (a) one vaccine and (b) two vaccines for each of the different vaccines.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	29085
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>The following table shows the latest summary of evidence on vaccine effectiveness against different outcomes, including transmission, for Pfizer/BioNTech and University of Oxford/AstraZeneca as of 1 July 2021.</p><p> </p><table><tbody><tr><td rowspan="3"><p>Outcome</p></td><td colspan="4"><p>Vaccine Effectiveness</p></td></tr><tr><td colspan="2"><p>Pfizer/BioNTech</p></td><td colspan="2"><p>Oxford/AstraZeneca</p></td></tr><tr><td><p>1 dose</p></td><td><p>2 doses</p></td><td><p>1 dose</p></td><td><p>2 doses</p></td></tr><tr><td><p>Symptomatic disease</p></td><td><p>55-70%*</p></td><td><p>85-95%*</p></td><td><p>55-70%*</p></td><td><p>70-85%**</p></td></tr><tr><td><p>Hospitalisation</p></td><td><p>75-85%*</p></td><td><p>90-99%**</p></td><td><p>75-85%*</p></td><td><p>80-99%***</p></td></tr><tr><td><p>Mortality</p></td><td><p>70-80%**</p></td><td><p>95-99%**</p></td><td><p>75-85%**</p></td><td><p>75-99%***</p></td></tr><tr><td><p>Infection</p></td><td><p>55-70%**</p></td><td><p>70-90%***</p></td><td><p>60-70%***</p></td><td><p>No data</p></td></tr><tr><td><p>Transmission (secondary cases)^</p></td><td><p>45-50%***</p></td><td><p>No data</p></td><td><p>35-50%***</p></td><td><p>No data</p></td></tr></tbody></table><p> </p><p>Source: Table 3, <a href="https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fpublications%2Fcovid-19-vaccine-surveillance-report&amp;data=04%7C01%7Ccovid19surv%40phe.gov.uk%7Cb2598e32058644d021bf08d916c0fea2%7Cee4e14994a354b2ead475f3cf9de8666%7C0%7C0%7C637565840415583246%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=MFmH8qQxqsBUGSNXnO5e7tyCyPWBtYpuq%2FF3GUfu6AI%3D&amp;reserved=0" target="_blank">https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-report</a></p><p> </p><p>Notes:</p><ol><li>*High Confidence - Evidence from multiple studies which is consistent and comprehensive.</li><li>**Medium Confidence - Evidence is emerging from a limited number of studies or with a moderately level of uncertainty.</li><li>***Low Confidence - Little evidence is available at present and results are inconclusive.</li><li>^effectiveness in reducing symptomatic secondary cases in households of a symptomatic index case.</li></ol><p> </p><p>Public Health England plans to publish vaccine effectiveness data for Moderna when more evidence becomes available.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 12/07/2021 15:50:18 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4471 label Biography information for Rachael Maskell

1344647

registered interest
date	07/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccination: Birmingham
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will provide written instructions to NHS Birmingham and Solihull Clinical Commissioning Group requiring them (a) to liaise with hon. Members in the planning of community vaccinations and (b) to provide hon. Members with at least seven days notice of planned community vaccination sessions.
tabling member constituency	Birmingham, Hodge Hill
tabling member printed	Liam Byrne
uin	28969
answer	answer is ministerial correction date of answer 27/07/2021 answer text <p>There are no plans to do so. Whilst it is encouraged that clinical commissioning groups (CCGs) do liaise with local leaders and hon. Members, CCGs are autonomous organisations. As such, there is no formal guidance on the level of interaction CCGs should have with hon. Members and this should be discussed at a local level.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 27/07/2021 15:36:53 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 13505 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1171 label Biography information for Liam Byrne

1344110

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus Certificates
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that UK residents vaccinated against covid-19 whilst abroad are able to be certified as so vaccinated in the UK.
tabling member constituency	Luton North
tabling member printed	Sarah Owen
uin	28345
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>Work is ongoing to determine which non-United Kingdom vaccines can be recognised in this country.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 12/07/2021 14:17:26 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4777 label Biography information for Sarah Owen

1344131

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Travel: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has received confirmation from EU counterparts that UK citizens who are fully vaccinated against covid-19 will not find their travel to EU countries affected as a result of their having received a dose of the AstraZeneca covid-19 vaccine from batch numbers 4120Z001, 4120Z002 or 4120Z003.
tabling member constituency	Ceredigion
tabling member printed	Ben Lake
uin	28293
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>The Serum Institute of India (SII) manufactures both Vaxzevria and Covishield, branded vaccines which are the same as the University of Oxford/AstraZeneca vaccine. All SII-made doses approved by the United Kingdom regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzevria’. The MHRA has not approved doses branded as ‘Covishield’ and none have been administered in the UK. All AstraZeneca vaccines given in the UK are the same product and appear on the NHS COVID Pass as Vaxzevria.</p><p>The European Medicines Agency has authorised the Vaxzevria vaccine and it is therefore recognised by the European Union.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 12/07/2021 08:43:57 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4630 label Biography information for Ben Lake

1344201

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) monitor covid-19 vaccination rates and (b) increase vaccine uptake among people who are homeless; if he will publish data to support vaccine uptake among homeless people; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	28141
answer	answer is ministerial correction date of answer 22/07/2021 answer text <p>People who are experiencing homelessness were prioritised for vaccination in phase one of the programme alongside those with underlying health conditions, as advised by the Joint Committee on Vaccination and Immunisation (JCVI). To ensure access, we have followed the JCVI recommendation that this group should be offered the vaccine without the need for a National Health Service number or general practitioner registration.</p><p>Vaccination rates amongst the homeless population is monitored at a regional level within England and is used to inform deployment decisions so that uptake is maximised where possible. Data on vaccination uptake is not currently available as it has not been centrally validated. This is because data provides a snapshot of homelessness rates and as such, any vaccine uptake data relating to homeless people and COVID-19 vaccination uptake is also an estimate that cannot currently be validated. NHS England and NHS Improvement continue to work with the Ministry of Housing, Communities and Local Government to support outreach services and further work is being done to explore the availability of effective on-street models. Local vaccination services also play a vital role in reaching vulnerable groups, including people experiencing homelessness.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 28237 question first answered 22/07/2021 14:28:05 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3930 label Biography information for Caroline Lucas

1344202

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make it his policy to prioritise potential covid-19 booster vaccinations for (a) people living with asthma and (b) unpaid carers.
tabling member constituency	Hornsey and Wood Green
tabling member printed	Catherine West
uin	28275
answer	answer is ministerial correction date of answer 12/07/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential COVID-19 booster vaccination programme on 30 June, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>The JCVI advises a two staged approach, with individuals in stage one offered a booster vaccine and flu vaccine as soon as possible from September. Individuals in stage two should be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible. The JCVI suggests those aged 16 to 49 years old who are in an influenza or COVID-19 at risk group which includes some sufferers of chronic respiratory disease and asthma, are currently included in stage two.</p><p>Based on the JCVI’s interim advice, those eligible in phase one of the COVID-19 vaccination programme are likely to be offered a booster which includes unpaid carers. Final decisions on the timing, scope and cohort eligibility, of any booster programme will be confirmed once the JCVI has provided their final advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 12/07/2021 14:20:52 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4523 label Biography information for Catherine West

1344217

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that covid-19 vaccination uptake among people who are homeless is in line with uptake among the general population.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	28237
answer	answer is ministerial correction date of answer 22/07/2021 answer text <p>People who are experiencing homelessness were prioritised for vaccination in phase one of the programme alongside those with underlying health conditions, as advised by the Joint Committee on Vaccination and Immunisation (JCVI). To ensure access, we have followed the JCVI recommendation that this group should be offered the vaccine without the need for a National Health Service number or general practitioner registration.</p><p>Vaccination rates amongst the homeless population is monitored at a regional level within England and is used to inform deployment decisions so that uptake is maximised where possible. Data on vaccination uptake is not currently available as it has not been centrally validated. This is because data provides a snapshot of homelessness rates and as such, any vaccine uptake data relating to homeless people and COVID-19 vaccination uptake is also an estimate that cannot currently be validated. NHS England and NHS Improvement continue to work with the Ministry of Housing, Communities and Local Government to support outreach services and further work is being done to explore the availability of effective on-street models. Local vaccination services also play a vital role in reaching vulnerable groups, including people experiencing homelessness.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 28141 question first answered 22/07/2021 14:28:05 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4436 label Biography information for Cat Smith